BNGOBionano Genomics, Inc.

BNGO Stock Price, Valuation & Chart | Bionano Genomics, Inc.

Compare

$1.270+0.05 (+4.10%)

At close · 02 Sept 2026, 08:00 pm

Sector: Healthcare Industry: Medical - Diagnostics & Research BNGO intrinsic value BNGO calculated fair value vs price

Overview Financials Dividends Ratios

BNGO Historical price chart

BNGO Key Stats

Fair Value

Disclaimer

Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.

Unlock

Market Capitalization14.57M

PE Ratio-0.29

EPS-4.37

Trading Volume299.07K

Today's High/Low1.27/1.2

Dividend Yield0.00

52 Week High/Low5.5/1.0

Shares Outstanding11.47M

BNGO Financial Statement

BNGO Analyst ratings

BNGO Analysis & performance metrics

BNGO Company profile

Bionano Genomics, Inc. provides genome analysis software solutions. It offers Saphyr, a sample-to-result solution for structural variation analysis by optical genome mapping…

Bionano Genomics, Inc. provides genome analysis software solutions. It offers Saphyr, a sample-to-result solution for structural variation analysis by optical genome mapping for genome analysis and understanding of genetic variation and function; Saphyr instrument, a single-molecule imager; Saphyr Chip, a consumable that packages the nanochannel arrays for DNA linearization; and Bionano…

BNGO Management team

Name

Position

Cory Kreeck

Global Head of People Operations

Stanislas Marin M.B.A., M.S.

Vice President of Global Sales

Jonathan Dixon J.D.

General Counsel & Secretary

Mark Adamchak CPA

Vice President of Accounting & Controller

Donna Polizio

Global Head of Market Access

Robert Erik Holmlin M.B.A., Ph.D.CEO

President, Chief Executive Officer, Chief Financial Officer & Director

Mark OldakowskiCOO

Chief Operating Officer

Alka Chaubey FACMG, Ph.D.

Chief Medical Officer

Name

Position

Cory Kreeck

Global Head of People Operations

Stanislas Marin M.B.A., M.S.

Vice President of Global Sales

Jonathan Dixon J.D.

General Counsel & Secretary

Mark Adamchak CPA

Vice President of Accounting & Controller

Donna Polizio

Global Head of Market Access

Robert Erik Holmlin M.B.A., Ph.D.CEO

President, Chief Executive Officer, Chief Financial Officer & Director

Mark OldakowskiCOO

Chief Operating Officer

Alka Chaubey FACMG, Ph.D.

Chief Medical Officer

Management Team

Cory Kreeck

Global Head of People Operations

Stanislas Marin M.B.A., M.S.

Vice President of Global Sales

Jonathan Dixon J.D.

General Counsel & Secretary

Mark Adamchak CPA

Vice President of Accounting & Controller

Donna Polizio

Global Head of Market Access

Robert Erik Holmlin M.B.A., Ph.D.CEO

President, Chief Executive Officer, Chief Financial Officer & Director

Mark OldakowskiCOO

Chief Operating Officer

Alka Chaubey FACMG, Ph.D.

Chief Medical Officer

Management

Cory Kreeck

Global Head of People Operations

Stanislas Marin M.B.A., M.S.

Vice President of Global Sales

Jonathan Dixon J.D.

General Counsel & Secretary

Mark Adamchak CPA

Vice President of Accounting & Controller

Donna Polizio

Global Head of Market Access

Robert Erik Holmlin M.B.A., Ph.D.CEO

President, Chief Executive Officer, Chief Financial Officer & Director

Mark OldakowskiCOO

Chief Operating Officer

Alka Chaubey FACMG, Ph.D.

Chief Medical Officer

Total 8 executives

BNGO Frequently asked questions

What is Bionano Genomics, Inc. (BNGO) Stock Price?

Current stock price of Bionano Genomics, Inc. (BNGO) stock is $1.270. The stock price is +4.10% higher in the session. The intraday range can be seen from this page. Volume of Bionano Genomics, Inc. (BNGO) stock is 299.07K.

Last updated at 02 Sept 2026, 08:00 pm.

Why is the Bionano Genomics, Inc. (BNGO) stock price going up or down today?

The stock price of Bionano Genomics, Inc. (BNGO) can change with earnings, company news, and overall market sentiment. Bionano Genomics, Inc. operates in the Healthcare / Medical - Diagnostics & Research market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the Bionano Genomics, Inc. stock expensive at its current price?

Whether Bionano Genomics, Inc. looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for BNGO on this page is -0.29. EPS on this page is -4.37. Compare those figures with peers and growth expectations before deciding if the current Bionano Genomics, Inc. price is justified.

How has the stock price of Bionano Genomics, Inc. (BNGO) performed historically?

Historical performance for Bionano Genomics, Inc. (BNGO) is shown on the price chart on this page. Review multi-period moves alongside volume to see how BNGO reacted to past earnings and market events.

Should I buy Bionano Genomics, Inc. (BNGO) stock, at this price?

Buying Bionano Genomics, Inc. (BNGO) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.